SP
Therapeutic Areas
AEON Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ABP-450 (prabotulinumtoxinA) | Episodic Migraine | Phase 2 |
Leadership Team at AEON Biopharma
RB
Rob Bancroft
President & CEO, Board Member
JB
John Bencich
Chief Financial Officer
AW
Alex Wilson
Chief Legal & Strategy Officer, Secretary
CO
Chad Oh, MD
Chief Medical Officer
JS
Jennifer Sy
Chief Accounting Officer
JF
Jost Fischer
Chairman and Board Member
EC
Eric Carter, MD, PhD
Board Member
MF
Marc Forth
Board Member
RP
Robert Palmisano
Board Member
ST
Shelley Thunen
Board Member